Related Experiment Videos

UVB light suppresses nitric oxide production by murine keratinocytes and macrophages

Runa Sur1, Diane E Heck, Thomas M Mariano

  • 1Department of Pharmacology and Toxicology, Rutgers University, Piscataway, NJ 08854, USA.

Biochemical Pharmacology
|November 6, 2002
PubMed

Insights

Ultraviolet B (UVB) light suppresses nitric oxide synthase type 2 (NOS2) expression and nitric oxide production in skin cells. This therapeutic effect in inflammatory skin conditions involves differential regulation in macrophages and keratinocytes.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Immunology

Background:

  • Nitric oxide (NO) mediates inflammation and cell growth in skin disorders.
  • Inducible nitric oxide synthase (NOS2) generates NO in keratinocytes and macrophages.
  • Interferon-gamma (IFN-gamma) induces NOS2 expression.

Purpose of the Study:

  • To investigate the effect of ultraviolet B (UVB) light on IFN-gamma-induced NOS2 expression.
  • To elucidate the molecular mechanisms of UVB action in keratinocytes and macrophages.

Main Methods:

  • Transient transfection assays with NOS2 promoter-luciferase constructs.
  • Analysis of transcription factor (Stat1, NF-kappaB) activity.
  • Measurement of NOS2 mRNA, protein, and NO production.

Main Results:

  • UVB suppressed IFN-gamma-induced NOS2 expression, mRNA, protein, and NO production in both cell types.
  • In macrophages, UVB inhibited NF-kappaB and partially reduced Stat1 activity, suppressing NOS2 promoter activity.
  • In keratinocytes, UVB stimulated NOS2 promoter activity, indicating downstream inhibition.

Conclusions:

  • UVB suppresses NOS2 gene expression in macrophages by inhibiting Stat1 and NF-kappaB.
  • In keratinocytes, UVB's inhibitory effect on NOS2 occurs downstream of promoter activity.
  • UVB's differential regulation of NOS2 in macrophages and keratinocytes has implications for treating inflammatory dermatoses.

Related Concept Videos